Extremely low birth weight infants who develop severe respiratory disease m
ay have special nutrient requirements imposed by a combination of enhanced
utilization of nutrients or the need for epithelial cell repair resulting f
rom the disease process, as well as to support catch-up growth, Inositol, f
ree fatty acids, vitamin E and vitamin A are proposed as nutrients for whic
h infants at risk of chronic pulmonary insufficiency may have special requi
rements. Of these nutrients, only for vitamin A does suggestive evidence ex
ist that high doses when given intramuscularly may reduce the incidence of
death or chronic lung disease, Exogenous steroid therapy (dexamethasone), w
hich is often used to improve pulmonary compliance in ventilated premature
infants, may compromise vitamin A status and induce restricted somatic and
bone mineral growth. Supplemental nutrition by means of enriched infant for
mulas has provided benefits in growth and bone mass accretion to infants re
covering from bronchopulmonary dysplasia up to 3-mo corrected age. This gro
wth advantage was not sustained over the subsequent 9 mo, suggesting that p
rolonged nutritional support is required until catch-up growth is complete.
Further studies are required to delineate the needs for specific nutrients
such as antioxidant vitamins and minerals or vitamin A that may play a rol
e in preventing severe chronic lung disease in premature infants, As well,
the role of supplemental nutrition (beyond the requirements of term infants
) to support catch-up growth and maintenance during the critical stages of
early development requires further investigation before evidence-based nutr
ient recommendations can be developed for this special population of infant
s.